The US Department of Health and Human Services awarded Moderna $590 million to continue developing a vaccine to protect against bird flu.
While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.
As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why.
The Stargate Initiative, spearheaded by several tech giants, has raised alarm in the most paranoid parts of the MAGA movement ...
Today on Rising, Robby Soave delivers radar on why Mark Zuckerberg, Elon Musk, Jeff Bezos and others have flocked to President Trump’s side. Robby and Niall Stanage react to key parts of Trump’s ...
We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...
The Trump Administration’s abrupt cancellation of National Institutes of Health meetings and grant reviews has sparked ...
Friday's Forbes Daily covers Bloomberg's UN climate pledge, judge blocks Trump's end to birthright citizenship, Oscar ...